Symbol Name ID |
H2-T23
histocompatibility 2, T region locus 23 MGI:95957 |
Allelic Composition Genetic Background |
Annotated Term | Reference |
H2-T23tm2Cant/H2-T23tm2Cant B6.129S6-H2-T23tm2Cant |
abnormal CD4-positive, alpha-beta T cell physiology | J:142087 |
decreased susceptibility to experimental autoimmune encephalomyelitis | J:142087 | |
H2-T23tm2Cant/H2-T23tm2Cant involves: 129S6/SvEvTac |
abnormal CD4-positive, alpha-beta T cell physiology | J:123555 |
H2-T23tm2Cant/H2-T23tm2Cant Tg(Tcra2D2,Tcrb2D2)1Kuch/? involves: 129S6/SvEvTac |
abnormal CD4-positive, alpha-beta T cell physiology | J:142087 |
increased susceptibility to experimental autoimmune encephalomyelitis | J:142087 | |
H2-T23tm3Cant/H2-T23tm3Cant Tg(Tcra2D2,Tcrb2D2)1Kuch/? involves: 129S6/SvEvTac * C57BL/6 |
abnormal CD4-positive, alpha-beta T cell physiology | J:142087 |
H2-T23tm3Cant/H2-T23tm3Cant Tg(TcraTcrb)425Cbn/? involves: 129S6/SvEvTac * C57BL/6 |
abnormal CD4-positive, alpha-beta T cell physiology | J:142087 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/17/2024 MGI 6.24 |
![]() |
|